2018
DOI: 10.1055/s-0038-1623531
|View full text |Cite
|
Sign up to set email alerts
|

Cross-evaluation of Pharmacokinetic-Guided Dosing Tools for Factor VIII

Abstract: Background Patients with severe and moderate haemophilia A are treated prophylactically with factor VIII (FVIII) concentrate. Individualization of prophylaxis can be achieved by pharmacokinetic (PK)-guided dosing. Aim In this study, the performance of three PK tools (myPKFiT, Web-Accessible Population Pharmacokinetic Service-Hemophilia [WAPPS] and NONMEM) is compared. Methods In 39 patients, with severe or moderate haemophilia A, blood samples were collected 4, 24 and 48 hours after adm… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
22
0
1

Year Published

2019
2019
2023
2023

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 21 publications
(24 citation statements)
references
References 24 publications
1
22
0
1
Order By: Relevance
“…This observation, not related to age, BMI or blood group, could be explained in part by slightly longer half-lives of BHK-derived rFVIII in comparison with CHO-derived rFVIII. 19,20 Some other limitations of our study have to be outlined. Firstly, a washout period was not systematic in our population, since threshold FVIII:C levels before injection were most frequently low (median 0.01 IU/mL; range 0.001-0.13 IU/mL).…”
Section: Discussionmentioning
confidence: 99%
“…This observation, not related to age, BMI or blood group, could be explained in part by slightly longer half-lives of BHK-derived rFVIII in comparison with CHO-derived rFVIII. 19,20 Some other limitations of our study have to be outlined. Firstly, a washout period was not systematic in our population, since threshold FVIII:C levels before injection were most frequently low (median 0.01 IU/mL; range 0.001-0.13 IU/mL).…”
Section: Discussionmentioning
confidence: 99%
“…Fortunately, recently developed population PK tools, such as WAPPS and MyPKFiT, have been shown to produce reliable estimates of PK parameters with significantly fewer blood samples and with no washout. Both of these programs use population PK models and Bayesian forecasting to determine the PK profiles of infused FVIII.…”
Section: Introductionmentioning
confidence: 99%
“…It is important to correct the predicted factor levels using the residual or endogenous baseline levels, as doing not so will affect the estimation of the model parameters [77]. Not correcting for a residual pre-dose or baseline factor level may result in underestimation of Vd and/or overprediction of CL [78]. Therefore, the endogenous baseline factor level and the residual pre-dose factor level should be taken into account when a population PK model is constructed at least for patients with non-severe hemophilia.…”
Section: Discussionmentioning
confidence: 99%